Universe Pharmaceuticals’ $25 Million Initial Public Offering

Hunter Taubman Fischer & Li LLC represented Universe Pharmaceuticals in the transaction. Universe Pharmaceuticals INC, a China-based pharmaceutical manufacturer and distributor, closed its initial public offering of 5,000,000...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here